Carine VILLANUEVA BOUANANI

Dr. Carine VILLANUEVA BOUANANI


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2022 in SLEEP
Verified
Journal Article
Open access
PDF file
LALaura Arvis
Laura Arvis
EDEmilie Doye
Emilie Doye
KPKevin Perge
Kevin Perge
MZMin ZHANG
Min ZHANG
MTMarine Thieux
Marine Thieux
CBCarine VILLANUEVA BOUANANI
Carine VILLANUEVA BOUANANI
Study Objectives: Narcolepsy with cataplexy is associated with obesity in children. We proposed to assess whether metabolic complications were linked to narcolepsy regardless of obesity. The second aim of the study was to compare endocrine comorbidities in obese children with narcolepsy and control patients. Methods: We performed a case-control study in Pediatric Sleep Unit and Pediatric Endocrinology Unit of Woman Mother Child Hospital (Lyon, France) comparing 22 children with narcolepsy with 22 sex-, pubertal stage-, and BMI-matched non-syndromic obese patients. Clinical examination, biological measurements including an oral glucose tolerance test, and abdominal ultrasound were performed. Results: No difference regarding glucidic, lipid profile, hepatic, respiratory, and cardiovascular parameters were found between narcoleptic and control participants. Insulin sensitivity did not differ between the two groups. Control patients had more first-degree family history of overweight or obesity than children with narcolepsy (83% vs. 50%, p = .05). Prevalence of precocious puberty in children with narcolepsy was not higher than in control participants, but all the cases of advanced puberty involved children with narcolepsy who were diagnosed before 11 years old. All cases of central hypothyroidism belong to the narcoleptic group, who presented lower thyroid-stimulating hormone and fTA values compared to control children (respectively p = .03 and p = .001). Conclusions: No difference regarding metabolic complications was found between children with narcolepsy and control participants. Thus, metabolic disorders may be related to weight gain rather than a narcolepsy-specific risk. The presence of hypothyroidism and advanced puberty suggests a global involvement of hypothalamic structures in children with narcolepsy.

18 May 2024 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
LBLucie Bazus
Lucie Bazus
KPKevin Perge
Kevin Perge
SCSara Cabet
Sara Cabet
CMCarmine Mottolese
Carmine Mottolese
CBCarine VILLANUEVA BOUANANI
Carine VILLANUEVA BOUANANI

22 December 2022 in Cancers
Verified
Journal Article
Open access
PDF file
CPColine Puvilland
Coline Puvilland
CBCarine VILLANUEVA BOUANANI
Carine VILLANUEVA BOUANANI
AHAnaëlle Hemmendinger
Anaëlle Hemmendinger
LKLaure Kornreich
Laure Kornreich
IGIva Gueorguieva
Iva Gueorguieva
PLPierre LEBLOND
Pierre LEBLOND
There is little scientific evidence regarding the safety of GHRT in LGG, where GH deficiency is common. Purpose: to compare the recurrence rate in children with midline LGG, depending on whether or not they have received GHRT, in order to assess its impact on the risk of tumor recurrence. Methods: This bicentric retrospective study included 124 patients under the age of 18 who were diagnosed with a midline low-grade glial tumor between 1998 and 2016. We also reviewed literature on this subject. The main outcome measure was tumor relapse, demonstrated by brain MRI. Results: There were 17 patients in the GH-supplemented group (14%) and 107 patients in the non-supplemented group (86%). Relapse occurred in 65 patients (45.5%); 7 patients died (4.9%); no deaths occurred in patients receiving GHRT. Two patients developed a second tumor (1.4%), none of which had received GHRT. Relapse concerned 36.4% of patients without GHRT and 52.9% of patients with GHRT. The difference was not statistically significant between the two groups (p = 0.3). Conclusion: GHRT does not lead to a statistically significant increase in risk of relapse for pediatric midline low-grade pediatric glioma in our cohort. Although these results appear reassuring, future natural history or prospective studies should be done to ascertain these findings. Nevertheless, these reassuring data regarding GHRT are in agreement with the data in the current literature.

20 September 2025 in Endocrine
Verified
Journal Article
Closed access
PDF file
MGMarina Coppens Gouttin
Marina Coppens Gouttin
KPKevin Perge
Kevin Perge
ACAlain Calender
Alain Calender
EDEmilie Doye
Emilie Doye
APAude Brac de la Perrière
Aude Brac de la Perrière
CBCarine VILLANUEVA BOUANANI
Carine VILLANUEVA BOUANANI